Summary of Conference Call Company and Industry - The conference call pertains to a semiconductor materials company, focusing on advanced process materials and components for the semiconductor industry. Key Points and Arguments 1. **Production and Profitability**: The company has significantly increased production scale while maintaining industry-leading profitability, with a focus on strategic business areas such as 8-inch light meal polishing and wafer slicing. The cost reduction and efficiency improvement efforts in 2024 have led to a narrowing of losses and a balance between evaluation certification and economic benefits [1][4]. 2. **Gross Margin Recovery**: The gross margin for the main business, large diameter materials, has recovered to 64%, reflecting the company's resilience through market fluctuations since its IPO in 2020 [2]. 3. **Growth of Emerging Business**: The growth-oriented business segment has reached 40% of total revenue in 2024, indicating the establishment of a second growth curve for the company [2]. 4. **Domestic Revenue Share**: Domestic revenue now accounts for 70% of the main business income, showcasing significant progress in the localization process within China [2]. 5. **Technological Innovation**: The rise of open-source models in AI, such as DeepSeek, is expected to disrupt the dominance of tech giants in data algorithms and computing power, fostering innovation in the semiconductor sector [3]. 6. **Market Demand and Capacity Expansion**: The company is experiencing strong downstream demand, with expectations for continued growth in 2025. The current order status remains robust, with production capacity expansion underway [7][10]. 7. **High-End Product Focus**: The company aims to maintain a high-end product sales structure while expanding production capacity based on downstream customer orders, particularly in the local Chinese market [4]. 8. **Component Market Dynamics**: The component segment has seen a threefold increase in performance, with a gross margin improvement of 5 percentage points, indicating strong market potential [6]. 9. **Future Outlook**: The company is optimistic about the semiconductor cycle in 2025, driven by next-generation consumer electronics. The demand for larger diameter products is expected to grow, aligning with technological advancements in logic and storage processes [13][20]. 10. **Challenges in Certification and Supply**: The company is actively working on certification processes for large diameter silicon materials with major manufacturers, facing competitive pressures in the market [22]. 11. **Price Sensitivity and Stability**: The pricing of the company's products is not highly sensitive, with a focus on stable supply and meeting specific technical requirements from customers [20]. 12. **Strategic Development**: The company is exploring domestic and international collaboration opportunities while ensuring asset quality and synergy with its core business [5]. Other Important but Possibly Overlooked Content - The company acknowledges the cyclical nature of the semiconductor industry, with expectations for improved predictability in performance due to the establishment of a second growth curve [34]. - The management emphasizes the importance of maintaining high gross margins while navigating the competitive landscape, particularly in the high-end market segments [28]. - The company is cautious about potential acquisitions, focusing on maintaining a balance between growth opportunities and risk management [27]. This summary encapsulates the key insights and strategic directions discussed during the conference call, highlighting the company's performance, market dynamics, and future outlook in the semiconductor industry.

锦州神工半导体股份有限公司 2024 年年度股东大会会议资料 锦州神工半导体股份有限公司 2024 年年度股东大会 会议资料 二○二五年四月 1 | 目录 | | --- | | 锦州神工半导体股份有限公司 | | 2024 年年度股东大会会议须知 3 | | --- | --- | --- | | 锦州神工半导体股份有限公司 | | 2024 年年度股东大会会议议程 5 | | 议案一： | 《关于公司 | 2024 年年度报告及其摘要的议案》 7 | | 议案二： | 《关于 | 2024 年度董事会工作报告的议案》 8 | | 议案三： | 《关于 | 2024 年度监事会工作报告的议案》 14 | | 议案四： | 《关于公司 | 2024 年度财务决算报告的议案》 18 | | 议案五： | 《关于公司 | 2025 年度财务预算报告的议案》 21 | | 议案六： | 《关于公司 | 2024 年度利润分配方案的议案》 23 | | 议案七： | 《关于续聘 | 2025 年度审计机构的议案》 25 | | 议案八： | 《关于 | 2025 年度董事薪酬方案的议案》 26 | | 议案九： | ...

证券代码：688233 证券简称：神工股份 公告编号：2025-013 锦州神工半导体股份有限公司 美国政府已于近日发布了关于所谓"对等关税"的行政令，宣布美国对贸易 伙伴加征 10%的"最低基准关税"，并对某些贸易伙伴征收更高关税，引发市场 高度关注。锦州神工半导体股份有限公司（以下简称"公司"）持续密切关注全 球贸易政策。本次美国加征关税，对公司可能会产生的影响及公司采取的应对措 施如下： 一、本次加征关税对公司业务的影响 本次加征关税，对公司经营管理没有造成实质性影响。公司近年来没有对 美国商品的直接采购，仅有少量零部件及原材料的间接采购。因此，本次加征 关税对公司现有采购的影响有限，在可控范围内。2024 年度，公司及下属子公 司境外销售占比仅为公司总收入的 30%，且其中没有对美国销售。 关于关税政策对公司影响的自愿性信息披露公告 本公司董事会、全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 公司将密切关注国际、国内政策动态，积极主动地与供应商、客户沟通，对 政策可能出现的变动及时做出积极应对；此外，公司还将持续加强中国本土国 ...

报名：首届全球眼科大会 | 议程更新 报名：首届全球心血管大会 | 奖项申报 报名：首届全球骨科大会 | 奖项评选 合作伙伴征集：2025全球手术机器人大会 2025年4月8日至11日， 第91届中国国际医疗器械（春季）博览会（CMEF） 将在上海国家会展中心拉开帷幕。作为亚太地区规模最大的医疗科技展会，CMEF始终 是行业风向标，不仅汇聚全球创新技术，更见证着产业发展的新趋势。本届展会预计吸引 全球30多个国家和地区的近 5000家 企业，携 数万款 前沿产品集中亮相 ，以"创新科技，智领未来"为主题，共同探讨医疗科技的突破与未来。 CMEF不仅是一场产品与技术的集中展示，更是医疗行业生态的一次深度联动。从人工智能驱动的医学影像，到手术机器人赋能精准医疗，从智慧医院建设，到国 产医疗设备的崛起，CMEF2025通过高规格论坛、产业对话和技术展示，构建起全方位的交流平台，为行业发展提供新的思路与动能。 在这一医疗科技的年度盛会上，哪些企业将携最新技术亮相？哪些创新产品值得重点关注？ 思宇梳理了本届CMEF的亮点企业，一起来看它们如何在这场科技盛宴 中抢占先机！ P.S. 展位图附于文末，感兴趣的读者可按图索骥 ...

Group 1: Company Insights - Shen Gong Co., Ltd. - In 2024, Shen Gong Co., Ltd. is projected to achieve revenue of 302 million yuan, representing a year-on-year growth of 124%, with a net profit of 41.15 million yuan, marking a return to profitability [1] - The main business segment of large-diameter silicon materials is expected to see a revenue increase of 108%, with a gross margin of 64%, primarily due to reduced raw material costs and optimized product structure [1] - The growth segment of silicon components is anticipated to grow by 215%, accounting for 40% of total revenue, focusing on high-end products [1] - The company is optimistic about the semiconductor industry entering an upward cycle, driven by increased capital expenditure in AI data centers and the growth of domestic integrated circuit capacity in China [1] Group 2: Company Insights - Yi He Jia Ye - Yi He Jia Ye highlighted its development history and main products, emphasizing potential collaboration with Strong Brain Technology in the field of non-invasive brain-machine interface technology [2] - The company sees significant growth potential in the Chinese market for respiratory machines, noting the low diagnosis rate of sleep apnea diseases in China, indicating a vast market opportunity [2] - Yi He Jia Ye's products can legally and compliantly enter the U.S. market, with minimal impact from U.S. tariffs [2] - The company is working to build a complete commercial ecosystem in the respiratory machine sector and plans to expand its product and capability boundaries in the future [2]

Investment Rating - The report maintains a "Buy" rating for the company [2][7] Core Insights - The company's revenue for 2024 is projected to be 303 million yuan, representing a year-on-year growth of 124% [6][7] - The gross margin for silicon materials has recovered to 64%, with silicon component revenue increasing by 214.82% [7] - The company has established a strong position in the semiconductor industry, particularly in the production of silicon materials for etching processes [7] Financial Data and Profit Forecast - Total revenue is expected to grow from 135 million yuan in 2023 to 476 million yuan in 2025, with a year-on-year growth rate of 57.3% [6][9] - The net profit attributable to the parent company is forecasted to increase from -69 million yuan in 2023 to 150 million yuan in 2025, reflecting a significant turnaround [6][9] - The gross margin is projected to improve from 0.1% in 2023 to 53.0% in 2025 [6][9] Product and Market Position - The company has a comprehensive capability from crystal growth to silicon electrode production, making it one of the few domestic manufacturers with such integration [7] - Domestic revenue has increased significantly, accounting for 69.85% in 2024, up from 1.9% in 2019, driven by the rise of domestic semiconductor etching equipment [7] - The company is actively engaging with several 12-inch integrated circuit manufacturers, with numerous components already certified [7]

一、本次授权事项概述 证券代码：688233 证券简称：神工股份 公告编号：2024-010 根据《上市公司证券发行注册管理办法》《上海证券交易所上市公司证券发 行上市审核规则》《上海证券交易所上市公司证券发行与承销业务实施细则》等 相关规定，锦州神工半导体股份公司（以下简称"神工股份"或"公司"）于2025 年3月25日召开第三届董事会第四次会议，审议通过《关于提请股东大会授权董 事会以简易程序向特定对象发行股票的议案》，同意公司董事会提请股东大会授 权董事会决定公司向特定对象发行融资总额不超过人民币3亿元且不超过最近一 年末净资产20%的股票，授权期限为自公司2024年年度股东大会审议通过之日起 至公司2025年年度股东大会召开之日止。 锦州神工半导体股份有限公司 关于提请股东大会授权董事会以简易程序 向特定对象发行股票的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 二、本次授权事宜具体内容 本次提请股东大会授权事宜包括但不限于以下内容： （一）确认公司是否符合以简易程序向特定对象发行股票条件 授权董事会根据《 ...

1 2024 年度募集资金存放与实际使用情况的专项核查意见 国泰君安证券股份有限公司（以下简称"国泰君安"或"保荐机构"）作为 锦州神工半导体股份有限公司（以下简称"神工股份"或"公司"）首次公开发 行股票并在科创板上市、2023 年以简易程序向特定对象发行股票的保荐机构及 持续督导机构，根据《证券发行上市保荐业务管理办法》《上海证券交易所科创 板股票上市规则》《上海证券交易所科创板上市公司自律监管指引第 1 号——规 范运作》《上市公司监管指引第 2 号——上市公司募集资金管理和使用的监管要 求》等相关法律、法规和规范性文件的规定和要求，对公司 2024 年度募集资金 存放与实际使用情况进行了核查，核查情况及核查意见如下： 一、募集资金基本情况 （一）扣除发行费用后的实际募集资金金额、资金到账时间 1、2020 年首次公开发行股票 国泰君安证券股份有限公司 关于锦州神工半导体股份有限公司 经中国证券监督管理委员会《关于同意锦州神工半导体股份有限公司首次公 开发行股票的批复》（证监许可［2020］100 号）核准，公司采用战略配售、网上 网下方式发行人民币普通股（A 股）4,000 万股，发行价格为每股 21 ...

您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://ac.mof.gov.cn）"进行登 。 " | | | 目 | 录 | | | --- | --- | --- | --- | --- | | 序号 | | 内 | 容 | 页码 | | | 内部控制审计报告 | | | 1-2 | RSM 容诚 内部控制审计报告 锦州神工半导体股份有限公司 容诚审字[2025]110Z0018 号 容诚会计师事务所(特殊普通合伙) 中国 · 北京 内部控制审计报告 容诚审字[2025]110Z0018 号 锦州神工半导体股份有限公司: 按照《企业内部控制审计指引》及中国注册会计师执业准则的相关要求,我 们审计了锦州神工半导体股份有限公司(以下简称"神工股份")2024 年 12 月 31 日的财务报告内部控制的有效性。 一、企业对内部控制的责任 按照《企业内部控制基本规范》、《企业内部控制应用指引》、《企业内部 控制评价指引》的规定,建立健全和有效实施内部控制,并评价其有效性是神工 股份董事会的责任。 二、注册会计师的责任 我们的责任是在实施审计工作的基础上,对财务报告内部控制的有效性发表 审计意见, ...

审计报告 锦州神工半导体股份有限公司 容诚审字[2025]110Z0019 号 容诚会计师事务所(特殊普通合伙) 中国·北京 目 录 | 序号 | 容 内 | 页码 | | --- | --- | --- | | 1 | 审计报告 | 1-5 | | 2 | 合并资产负债表 | 1 | | 3 | 合并利润表 | 2 | | 4 | 合并现金流量表 | 3 | | 5 | 合并所有者权益变动表 | 4-5 | | 6 | 母公司资产负债表 | 6 | | 7 | 母公司利润表 | 7 | | 8 | 母公司现金流量表 | 8 | | 9 | 母公司所有者权益变动表 | 9-10 | | 10 | 财务报表附注 | 11-106 | 审 计 报 告 容诚审字[2025]110Z0019 号 容诚会计师事务所（特殊普通合伙） 总所：北京市西城区阜成门外大街 22 号 1 幢 10 层 1001-1 至 / 1001-26 (100037) TEL:010-6600 1391 FAX:010-6600 1392 E-mail:bj@rsmchina.com.cn https://www.rsm.global/chi ...